Autoimmune autonomic ganglionopathy

Frontiers of Neurology and Neuroscience

Volumn 26, Issue , 2009, Pages 85-93

  Winston, Nicole ^a   Vernino, Steven ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CHOLINERGIC RECEPTOR ANTIBODY; CHOLINESTERASE INHIBITOR; CORTICOSTEROID; EPHEDRINE; ERYTHROPOIETIN; FLUDROCORTISONE; IMMUNOGLOBULIN; IMMUNOSUPPRESSIVE AGENT; ION CHANNEL; MIDODRINE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NICOTINIC RECEPTOR; PYRIDOSTIGMINE; RITUXIMAB; THREO 3,4 DIHYDROXYPHENYLSERINE;

ABDOMINAL PAIN; ANHIDROSIS; ANISOCORIA; ANOREXIA; AUTOIMMUNE AUTONOMIC GANGLIONOPATHY; AUTONOMIC DYSFUNCTION; AUTONOMIC NEUROPATHY; BLURRED VISION; CONSTIPATION; DIARRHEA; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; DIZZINESS; DRY EYE; GASTROINTESTINAL MOTILITY DISORDER; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; IMPOTENCE; ORTHOSTATIC HYPOTENSION; PARASYMPATHETIC GANGLION; PARENTERAL NUTRITION; PLASMAPHERESIS; PRIORITY JOURNAL; REVIEW; SATIETY; SJOEGREN SYNDROME; SYMPATHETIC GANGLION; SYMPTOM; SYNCOPE; TACHYCARDIA; VOMITING; XEROSTOMIA; AUTOIMMUNE DISEASE; AUTONOMIC GANGLION; CHEMISTRY; IMMUNOLOGY;

AUTOIMMUNE DISEASES; AUTONOMIC NERVOUS SYSTEM DISEASES; GANGLIA, AUTONOMIC; HUMANS; RECEPTORS, NICOTINIC;

EID: 67649700463     PISSN: 16604431     EISSN: 16622804     Source Type: Book Series    
DOI: 10.1159/000212370     Document Type: Review

References (25)

1. Maguire AM, Craig ME, Craighead A, et al: Autonomic nerve testing predicts the development of complications: a 12-year follow-up study. Diabetes Care 2007;30:77-82.
2. Young RR, Asbury AK, Corbett JL, Adams RD: Pure pan-dysautonomia with recovery. Brain 1975;98: 613-636.
3. Suarez GA, Fealey RD, Camilleri M, Low PA: Idiopathic autonomic neuropathy: clinical, neurophysiologic, and follow-up studies on 27 patients. Neurology 1994;44:1675-1682.
4. Low PA Vernino S, Suarez G: Autonomic dysfunction in peripheral nerve disease. Muscle Nerve 2003;27:646-661.
5. Vernino S, Lennon VA: Autoantibody profiles and neurological correlations of thymoma. Clin Cancer Res 2004;10:7270-7275.
6. Lucchinetti CF, Camilleri M, Lennon VA: Gastrointestinal dysmotility spectrum in patients seropositive for paraneoplastic type 1 anti-neuronal nuclear autoantibodies. Clin Auton Res 1994;4:206.
7. Yu Z, Kryzer TJ, Griesmann GE, Kim K, Benarroch EE, Lennon VA: CRMP-5 neuronal autoantibody: marker of lung cancer and thymoma-related autoimmunity. Ann Neurol 2001;49:146-154.
8. Lucchinetti CF, Kimmel D W, Lennon VA: Paraneoplastic and oncologic profiles of patients seropositive for type 1 antineuronal nuclear autoantibodies. Neurology 1998;50:652-657.
9. Zochodne DW: Autonomic involvement in Guillain-Barré syndrome: a review. Muscle Nerve, 1994;17: 1145-1155.
10. Josephs KA, Silber MH, Fealey RD, Nippoldt TB, Auger RG, Vernino S: Neurophysiologic studies in Morvan syndrome. J Clin Neurophysiol 2004;21: 440-445.
11. Löscher WN, Wanschitz J, Reiners K, Quasthoff S: Morvan's syndrome: clinical, laboratory, and in vitro electrophysiological studies. Muscle Nerve 2004;30: 157-163.
12. Sandroni P, Vernino S, Klein CM, Lennon VA, Benrud-Larson L, Sletten D, Low PA: Idiopathic autonomic neuropathy: comparison of cases sero-positive and seronegative for ganglionic acetylcholine receptor antibody. Arch Neurol 2004;61:44-48.
13. Klein CM, Vernino S, Lennon VA, Sandroni P, Fealey RD, Benrud-Larson L, Sletten D, Low PA: The spectrum of autoimmune autonomic neuropathies. Ann Neurol 2003;53:752-758.
14. Vernino S, Low PA, Fealey RD, Stewart JD, Farrugia G, Lennon VA: Autoantibodies to ganglionic acetylcholine receptors in autoimmune autonomic neuropathies. N Engl J Med 2000;343:847-855.
15. Vernino S, Lindstrom J, Hopkins S, Wang Z, Low PA, Muscle Study Group: Characterization of ganglionic acetylcholine receptor autoantibodies. J Neuroimmunol 2008;197:63-69.
16. Rakocevic G, Barohn R, McVey AL, Damjanov I, Morte PD, Vernino S, Lennon V: Myasthenia gravis, thymoma, and intestinal pseudo-obstruction: a case report and review. J Clin Neuromuscul Dis 2003;5: 93-95.
17. Gibbons CH, Freeman R: Antibody titers predict clinical features of autoimmune autonomic ganglionopathy. Auton Neurosci 2009, E-pub ahead of print.
18. Sandroni P, Low PA: Other autonomic neuropathies associated with ganglionic antibody. Auton Neurosci 2008, E-pub ahead of print.
19. Singer W, Sandroni P, Opfer-Gehrking TL, Suarez GA, Klein CM, Hines S, O'Brien PC, Slezak J, Low PA: Pyridostigmine treatment trial in neurogenic orthostatic hypotension. Arch Neurol 2006;63:513-518.
20. Iodice V, Kimpinski K, Vernino S, Sandroni P, Low PA: Immunotherapy for autoimmune autonomic ganglionopathy. Auton Neurosci 2008, E-pub ahead of print.
21. Schroeder C, Vernino S, Birkenfeld AL, Tank J, et al: Plasma exchange for primary autoimmune autonomic failure. N Engl J Med 2005;353:1585-1590.
22. Vernino S, Low PA, Lennon VA: Experimental autoimmune autonomic neuropathy. J Neurophysiol 2003;90:2053-2059.
23. Vernino S, Ermilov LG, Sha L, Szurszewski JH, Low PA, Lennon VA: Passive transfer of autoimmune autonomic neuropathy to mice. J Neurosci 2004;24: 7037-7042.
24. Vernino S, Hopkins S, Wang Z: Autonomic ganglia, acetylcholine receptor antibodies, and autoimmune ganglionopathy. Auton Neurosci 2008, E-pub ahead of print.
25. Wang Z, Low PA, Jordan J, Freeman R, Gibbons CH, Schroeder C, Sandroni P, Vernino S: Autoimmune autonomic ganglionopathy: IgG effects on ganglionic acetylcholine receptor current. Neurology 2007;68:1917-1921.